Stock CCCC C4 THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders C4 Therapeutics, Inc.

Equities

CCCC

US12529R1077

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-03 pm EDT 		5-day change 1st Jan Change
4.84 USD -3.20% Intraday chart for C4 Therapeutics, Inc. -11.68% -14.34%
May. 09 Stifel Adjusts Price Target on C4 Therapeutics to $14 From $13, Maintains Buy Rating MT
May. 08 C4 Therapeutics Shares Decline as Q1 Revenue Misses Estimates MT

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
C4 Therapeutics, Inc. Appoints Owen Hughes to Its Board of Directors
CI
ImmunoGen Names Lauren White CFO
MT
C4 Therapeutics Appoints Kendra Adams as Finance Chief
MT
C4 Therapeutics, Inc. Announces Executive Changes, Effective as of September 18, 2023
CI
C4 Therapeutics, Inc. Appoints Mary Christian as Senior Vice President, Regulatory
CI
C4 Therapeutics, Inc. Appoints Leonard Reyno as Chief Medical Officer, Effective July 10, 2023
CI
C4 Therapeutics Chief Medical Officer Adam Crystal Plans to Resign
MT
C4 Therapeutics, Inc. Announces Executive Changes
CI
C4 Therapeutics, Inc. Appoints Laura Bessen and Donna Grogan to its Board of Directors
CI
C4 Therapeutics, Inc. Announces Alain J. Cohen Withdrawal as a Director Nominee for Re-Election At the 2022 Annual Meeting
CI
C4 Therapeutics, Inc. Announces Resignation of Elena Prokupets as Director and Member of the Audit, Compensation and Nominating and Corporate Governance Committees
CI
C4 Therapeutics Appoints Utpal Koppikar to Board of Directors and as Chair of the Audit Committee and A Member of the Organization, Leadership and Compensation Committee
CI
Insider Sell: C4 Therapeutics
MT
Insider Sell: C4 Therapeutics
MT
Insider Sell: C4 Therapeutics
MT
Insider Sell: C4 Therapeutics
MT
Insider Sell: C4 Therapeutics
MT
Laura J. Wahlberg to Resign from C4 Therapeutics, Inc. as Vice President, Finance, Corporate Controller and Principal Accounting Officer, Effective as of May 28, 2021
CI
C4 Therapeutics, Inc. Elects Glenn Dubin as A Director
CI
C4 Therapeutics, Inc. Appoints Kelly Schick as Chief People Officer
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CCCC Stock
  4. News C4 Therapeutics, Inc.
  5. Insiders